Section: Surgical Oncology Curriculum: Curriculum, page 64

Also see: Breast screening

Principles of Screening for malignancy

  • Screening of a population is used to detect disease in individuals without signs & symptoms of that disease.
  • The aim is early detection thus enabling early intervention & management in the hope to reduce mortality & morbidity,

Issues

  • Overdiagnosis – PSA – more men die with prostate cancer than of it
  • False positive
  • Misdiagnosis
  • False sense of security – false negative
  • Cost & use of medical resources
  • Adverse effects from screening – stress & anxiety, discomfort, radiation exposure, chemical exposure
  • Adverse effects from further Ix in false positive (ie: biopsy)

Biases

  • Lead-time bias
    • Two people, one screened, one not, the non-screened one picked up on symptoms 6 months later. Both die same day, it could look like screened patient had survival advantage as had longer survival from diagnosis
  • Length bias – screening more likely to pick up slower growing tumours
  • Selection bias – there will be differences in those that choose to take up screening

Types

  • Universal screening – screening of all individuals in a certain category
  • Case finding – screening a smaller group based on the presence of risk factors (family member been diagnosed with a hereditary disease)

WHO principles of population screening

  • Important health problem
  • Recognisable latent or early symptomatic stage
  • The natural history is understood
  • Accepted treatment
  • Suitable test or examination that has a high level of accuracy
  • Test should be acceptable to the population
  • Agreed policy on whom to treat as patients
  • Facilities for diagnosis and treatment should be available
  • Cost of screening should be economically balanced in relation to possible expenditure on medical care as a whole
  • Screening should be a continuing process

NZ screening tests

  • Foetal – eg PKU, hypothyroidism, CF, congenital adrenal hyperplasia (CAH)
  • Breast cancer screening
  • cervical cancer screening
  • Mantoux for Tb
  • FOB & Colonoscopy

Sensitivity & Specificity

  • sensitivity = proportion of people with the disease who test positive (a/a+c)
  • specificity = proportion of people without the disease who test negative (d/d+b)
  • +ve predictive value = chance that people have the disease if they test positive (a/a+b)
    • increases when the prevalence in a population is high
  • -ve predictive value = chance that people don’t have the disease if they test -ve (c/c+d)
    • increases when the prevalence in a population is low